Black Lung Disease Facts

Black Lung Disease Facts

Black lung disease is a chronic respiratory condition that results from the long-term inhalation of coal dust. When inhaled into the lungs, these tiny particles can accumulate, cause inflammation, produce tissue scarring and diminish lung function. Specifically, a buildup of mineral dust can significantly reduce the ability of the lungs to take in oxygen, release carbon dioxide and facilitate the exchange of oxygen and carbon dioxide in the blood.

Also known as coal worker’s pneumoconiosis, black lung disease is not well understood, especially outside of the mining profession. Here are some basic facts about the condition:

  • Even though black lung disease often produces the same symptoms as chronic obstructive pulmonary disease (COPD) – most notably, persistent coughing and shortness of breath – the two conditions are addressed differently.
  • Because coal worker’s pneumoconiosis cannot be cured or reversed, the aim of treatment is to alleviate symptoms, slow the progression of lung tissue scarring and improve quality of life.
  • Black lung disease can cause a healthy pink lung to become visibly blackened over time.
  • Smoking does not cause coal worker’s pneumoconiosis, nor does it increase the risk of developing the condition or alter its progression.
  • Due to the introduction of stringent coal dust control measures, black lung disease was all but eliminated by the 1970s. Recently, however, its prevalence has dramatically increased, possibly due to a relaxation of safety standards in the mining industry.

Many people who are diagnosed with black lung disease are able to manage their symptoms by avoiding further exposure to coal dust, taking medications and using supplemental oxygen. Additionally, the Lung Institute offers cellular therapy, which involves the harvesting and reintroduction of a patient’s own cells, which can help reduce inflammation and promote the healing of lung tissue. Many people who undergo stem cell treatment for pneumoconiosis report not only an improvement in their quality of life, but also a reduced dependence on supplemental oxygen and medications.

If you’re living with black lung disease, you may be interested in learning about our innovative cellular therapy options. Please contact us today at (800) 729-3065. We look forward to helping you breathe easier.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.